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The acute and long-term consequences of traumatic brain injury (TBI) have received increased attention in
recent years. In this Review, we discuss the neuropathology and neural mechanisms associated with TBI,
drawing on findings from sports-induced TBI in athletes, in whom acute TBI damages axons and elicits
both regenerative and degenerative tissue responses in the brain and in whom repeated concussions may
initiate a long-term neurodegenerative process called dementia pugilistica or chronic traumatic encephalop-
athy (CTE). We also consider how the neuropathology and neurobiology of CTE in many ways resembles
other neurodegenerative illnesses such as Alzheimer’s disease, particularly with respect to mismetabolism
and aggregation of tau, b-amyloid, and TDP-43. Finally, we explore how translational research in animal
models of acceleration/deceleration types of injury relevant for concussion together with clinical studies em-
ploying imaging and biochemical markers may further elucidate the neurobiology of TBI and CTE.Introduction
Head trauma with concussion is common in boxing and other
contact sports, such as American football and ice hockey. It is
almost 100 years since chronic brain damage in boxers, known
as punch drunk syndrome (Martland, 1928) or dementia pugilis-
tica (Millspaugh, 1937), was described. In recent years, chronic
brain damage in high-profile American football players has also
received increasing attention, both in the press and in the
medical and scientific community. In the United States alone,
about 300,000 sports-related concussions occur annually (El-
lenbogen et al., 2010), and numbers are increasing worldwide
(Hootman et al., 2007), and repeated concussions are thought
to result in a syndrome called chronic traumatic encephalopathy
(CTE). This article reviews the medical literature on mild trau-
matic brain injury (TBI), a term that is used interchangeably
with concussion, and the chronic syndrome dementia pugilistica
or CTE. We focus on findings revealed by the study of mild
TBI and CTE in contact sport athletes, with the consideration
that studies on the neuropathology and neurobiology in sports
athletes will provide valuable insights into the neurobiological
changes and mechanisms that are probably characteristic of
TBI more generally.
Types of Traumatic Brain Injury
Brain injury as a result of head trauma generally falls into two
categories. Acute brain injury comprises mild TBI or concussion
including its short-term sequelae and catastrophic brain injury
that may lead to death, most commonly due to subdural hema-
toma. Chronic brain injury, called dementia pugilistica or CTE, is
a neurodegenerative disorder due to repeated head trauma and,
in the case of professional boxers and other contact sports
athletes, often starts several years after the sports career ends.
We note an important distinction between amateur and profes-
sional boxing, as differences in rules have prevented TBI from886 Neuron 76, December 6, 2012 ª2012 Elsevier Inc.being as severe a problem in the amateur version of the sport.
In the next few sections, we describe the general phenome-
nology of these different categories of brain injury, aswell as their
prevalence.
Concussion
There is little agreement among medical professionals on how
to define or diagnose concussion. An international consensus
statement on concussion in sport defines concussion as ‘‘a com-
plex pathophysiological process affecting the brain, induced by
traumatic biomechanical forces’’ (Quality Standards Subcom-
mittee, 1997; McCrory et al., 2009). Concussion causes no gross
pathology, such as hemorrhage, and no abnormalities on struc-
tural brain imaging (McCrory et al., 2009). Mild concussion
causes no loss of consciousness, but many other complaints
such as dizziness, nausea, reduced attention and concentra-
tion, memory problems, and headache. More severe concussion
also causes unconsciousness, which may be prolonged. For
example, in boxing, a knockout is associated with acute brain
damage due to concussion with unconsciousness. Not surpris-
ingly, concussion occurs more often in professional boxing
than in amateur boxing and other contact sports (Koh et al.,
2003). The medical literature on martial arts such as kickboxing,
taekwondo, and ultimate fighting is much less extensive than for
boxing, but some studies have shown that the incidence of
concussion per 1,000 athlete exposures is about 50 for taek-
wondo and 70 for kickboxing athletes (Zazryn et al., 2003; Koh
and Cassidy, 2004). Concussive head impacts are also very
frequent in American football. Athletes, especially linemen and
linebackers, may be exposed to more than 1,000 impacts per
season (Crisco et al., 2010).
Medical professionals have known for a long time that many
patients who sustained minor head trauma have persistent com-
plaints. This clinical entity is called postconcussion syndrome
(PCS) and is defined as transient symptoms after brain trauma,
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cognitive problems such as impaired memory, attention, and
concentration (Hall et al., 2005). Between 40%–80% of individ-
uals exposed to mild head injury experience some PCS symp-
toms; most recover within days to weeks, while about 10%–
15% have persistent complaints after 1 year (Hall et al., 2005;
Sterr et al., 2006). In the same way, neuropsychological deficits
after mild concussion or a knockout last longer than subjectively
experienced or reported by boxers. Amateur boxers have mea-
surable impairment in cognitive functioning in the days after
a knockout (Bleiberg et al., 2004). Further, poor cognitive perfor-
mance during a 1 month recovery period was found in profes-
sional boxers with high exposure to professional bouts (Ravdin
et al., 2003). Results from a survey of 600 Japanese professional
boxers indicated that 30% reported complaints after a knockout,
including headache, nausea, visual disturbances, tinnitus, leg or
hand weakness, and forgetfulness, that continued often days
after a boxing bout (Ohhashi et al., 2002).
Catastrophic Brain Injury
Catastrophic brain injury refers to acute severe brain injury, with
intracranial bleeding or cerebral contusions, that may lead to
death. In boxing, about ten deaths have occurred annually
during the 20th century; most were related to knockout or tech-
nical knockout (deaths due to boxing are registered in the Man-
uel Velazquez Boxing Fatality Collection, available at http://
ejmas.com/jcs/jcsart_svinth_b_0700.htm). The most common
cause of death is subdural hematoma (Guterman and Smith,
1987; Unterharnscheidt, 1995). Most deaths (about 80%) are
among professional boxers, and boxing-related deaths due to
brain damage occur in all rounds and in all weight classes, but
somewhat surprisingly, most deaths are in lower weight classes.
Deaths declined since 1983, which might be related to lower
exposure to repetitive head trauma among professional boxers
with shorter careers and fewer fights (Baird et al., 2010). Cata-
strophic brain injury also occurs in American football. During
the second half of the 20th century, more than 400 players
died from brain or spinal cord injury in the United States while
playing (McIntosh and McCrory, 2005).
Chronic Traumatic Encephalopathy
Repetitive brain trauma may cause chronic neurological prob-
lems. For example, in 1928, Martland (1928) described chronic
brain damage in boxers, which was termed punch drunk syn-
drome. A few years later, Millspaugh (1937) called this syndrome
dementia pugilistica, which is more commonly used. Forty years
ago, Corsellis et al. (1973) described neuropathological changes
in a series of professional boxers with dementia pugilistica. Their
key findings included neurofibrillary tangles in cortical areas,
cerebellar atrophy and gliosis, hypopigmentation of the substan-
tia nigra, and cavum septum pellucidum. Many years after these
early studies documenting the histopathological changes in
career boxers, it became evident that a similar chronic brain
condition occurred in athletes who practiced other contact
sports and had a history of repeated head trauma, and it was
only recently that the first autopsy report from a football player
was published (Omalu et al., 2005). Neuropathological changes
were similar to those in boxers with dementia pugilistica, findings
that have now been verified in larger studies (McKee et al., 2009).
These authors introduced the more general term chronic trau-matic encephalopathy (CTE), which has gained broader usage
(Stern et al., 2011). CTE is regarded as a chronic brain syndrome
due to effects of repetitive brain trauma, but there are no gener-
ally accepted guidelines for a clinical diagnosis of CTE or for how
to distinguish neuropathological changes due to CTE from those
due to aging and Alzheimer’s disease (AD).
CTE is regarded as a neurodegenerative disorder that often
occurs in midlife, years or decades after the sports career has
ended (McKee et al., 2009). About one-third of CTE cases are
progressive (Roberts, 1969), but clinical progression is not
sequential or predictable. Clinical symptoms vary extensively,
which is probably due to varying, multiple damage sites among
boxers with the condition. CTE severity varies from mild com-
plaints to severe deficits accompanied by dementia, Parkin-
son-like symptoms, and behavioral changes (Stiller and Wein-
berger, 1985; Mendez, 1995).
Clinical symptoms include neurological and cognitive com-
plaints together with psychiatric and behavioral disturbances
(Mendez, 1995; Jordan, 2000). Early neurological symptoms
may include speech problems and impaired balance, while later
symptoms include ataxia, spasticity, impaired coordination, and
extrapyramidal symptoms, with slowness of movements and
tremor (Stiller and Weinberger, 1985; Mendez, 1995; Jordan,
2000; McKee et al., 2009). Cognitive problems, such as attention
deficits and memory disturbances, often become major factors
in later stages of the disease (Roberts, 1969; Jordan, 2000; Gu-
terman and Smith, 1987). Psychiatric and behavioral problems
include lack of insight and judgment, disinhibition and euphoria,
hypomania, irritability, and aggressiveness. The problems occur
at varying times throughout the course of CTE (Roberts, 1969;
Jordan, 2000; Guterman and Smith, 1987).
There are no large epidemiological studies on CTE prevalence
among boxers and such a study is clearly needed. Some older
studies suggest that prevalence of severe CTE in professional
boxers is about 20% (Roberts, 1969; Jordan et al., 1997). It
has also been suggested that around one-third of retired profes-
sional boxers have clinical symptoms, such as memory and
speech disturbances, and most perform very poorly on formal
cognitive tests (Casson et al., 1984). A study on professional
boxers showed that 16% had complaints in daily life, e.g., head-
ache, visual and hearing disturbances, one-sided weakness in
legs or hands, shaky hands, and forgetfulness (Ohhashi et al.,
2002). Furthermore, recent MRI studies show that 76% of
professional boxers have abnormalities, such as hippocampal
and cortical atrophy, dilated perivascular spaces, and diffuse
axonal injury (DAI); these abnormalities also correlate with career
length and number of bouts (Orrison et al., 2009).
In contrast, studies in amateur boxers found no change over
time in neuropsychological test scoreswhen comparing amateur
boxers with long careers (25–180 bouts) and short careers (0–15
bouts) (Haglund and Persson, 1990) and no change in neuro-
psychological measurement results during a 9 year period
(Porter, 2003). A recent meta-analysis found no strong relation-
ship between amateur boxing and CTE (Loosemore et al.,
2008). The reason for this difference between professional and
amateur boxing is under debate but is probably due to the
substantially lower number of rounds in amateur boxing and to
the more liberal use of the referee stops contest rule to stop anNeuron 76, December 6, 2012 ª2012 Elsevier Inc. 887
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There are no available data on the prevalence of CTE among
athletes active in martial arts such as kickboxing and ultimate
fighting.
Biophysical Mechanisms for Brain Injury
Cerebrospinal fluid (CSF) bathes the brain and provides a protec-
tive environment. Despite this protection, blunt head injury—
even without skull fracture—can damage fragile brain tissue
via acceleration and deceleration forces. In the next sections,
we will review the principally different types of head blows
from which the force to the head is transmitted to the brain,
which leads to tearing of the long axons that interconnect brain
regions, and the vulnerability of the brain for repeated head
trauma.
Types and Impact of Blows
There are two main principal types of head blows in boxing: (1)
a straight impact to the face that generates linear acceleration
of the head and (2) impact to the side of the face or from below
to the chin that creates rotational acceleration (Unterharn-
scheidt, 1995). Studies report that head trauma, which causes
linear acceleration of the brain, is relatively well tolerated, while
the brain is more sensitive to angular acceleration (Cantu,
1996). Boxing punches result in proportionately more rotational
than linear acceleration of the head, and a study on professional
boxers verified that hook punches, which turn the head laterally
with rotational acceleration of the brain, cause more concus-
sions than parallel blows (Ohhashi et al., 2002). The opposite is
true for other sports, such as football, in which the force often
is directed toward the center of the head, which results in trans-
lational, or linear, acceleration (Viano et al., 2005).
Results from studies on the biomechanical forces to the head
in boxing have shown that rotational acceleration of a punch
is higher for the heavier weight classes, with punch severity
increasing with weight class (Walilko et al., 2005). A punch
from a professional boxer may generate amajor force on impact,
which, transferred to daily life, may be compared to being hit
in the head by a 6 kg bowling ball that rolls at 20 mph (Atha
et al., 1985). Indeed, many articles support the contention that
boxing-related CTE is due to cumulative effects of repeated
head blows. This view is, among other things, based on the
knowledge that risk factors for CTE in professional boxers
include a long boxing career, many bouts, high sparring expo-
sure, many knockouts, poor performance as a boxer, and being
able to tolerate many blows without being knocked out (Jordan,
2000).
Susceptibility for Repeated Trauma
Repeated blows to the head are especially detrimental for the
brain, because the cerebral physiology is disturbed after mild
brain trauma and concussions, which makes the brain more
susceptible to further injury. Indeed, extensive animal experi-
mental data indicate that repeated mild head injury with axonal
damage increases brain vulnerability for additional concussive
impacts (Barkhoudarian et al., 2011; Laurer et al., 2001). In
line with these findings, American football players with a history
of repeated concussions have a markedly increased risk for
memory problems and cognitive impairment (Guskiewicz et al.,
2005).888 Neuron 76, December 6, 2012 ª2012 Elsevier Inc.The cellular mechanisms for the increased susceptibility of the
brain to repeated brain trauma are multifaceted. Researchers
argue that metabolic dysfunction, including reduced mito-
chondrial energy status in the brain with increased metabolic
demands but decreased energy stores with a low ATP/DTP ratio
and increased lactate/pyruvate ratio, may play a role (Jenkins
et al., 1989; Vespa et al., 2005; Vagnozzi et al., 2008). Yuen
et al. (2009) suggested that mild trauma stimulates a type of
sodium channelopathy on axons, which, in turn, intensifies path-
ophysiological responses to succeeding minor injuries. Longhi
et al. (2005) reported that increased brain vulnerability after
repeated concussions occurs via axonal damage, which is sig-
nificantly amplified. In the next section, wemore closely consider
some of the molecular mechanisms underlying traumatic brain
injury.
Neurobiological Mechanisms of Traumatic Brain Injury
There are two main categories of brain damage due to trauma:
focal damage and diffuse injury. Focal injury includes cortical
or subcortical contusions and lacerations, as well as intracranial
bleedings (subarachnoid hemorrhage and subdural hematoma).
Focal injury is due to severe direct impact on the brain and is thus
mainly seen in severe cases of TBI. Diffuse injury is caused by
stretching and tearing of the brain tissue and does not need
any skull fracture or direct impact or crush injury to the brain
surface and is therefore also seen in cases with mild TBI. The
main form of diffuse injury is called diffuse axonal injury (DAI),
which is due to acceleration/deceleration forces that lead to
shearing of axons. In the following subsections, we discuss the
neurobiology of acute mild TBI or concussion, considering how
accurate this may be examined in different forms of animal
models. We also review the chronic degenerative brain disorder
CTE, which is found in contact sports athletes, and its similarity
to other neurodegenerative disorders, especially Alzheimer’s
disease and Parkinson’s disease (PD).
Animal Models for TBI
Animal models have been used in numerous studies to examine
the neurobiology and mechanisms of TBI. Many studies ex-
ploring the neurobiology and neurochemistry of acute TBI are
based on invasive animal TBI models in which the brain is
exposed by craniotomy, and the cortex is subjected to injury
by crush or compression, for example, by a rigid impactor
(controlled cortical impact), weight drop, vacuum deformation,
or by fluid percussion (for review, see O’Connor et al., 2011).
These direct crush animal TBI models have been found to have
a high variability in outcome, ranging from minor symptoms to
fatal outcome, from a minor change in impact (Nilsson et al.,
1990), which might limit their utility as models of human mild
TBI. Animal TBI models based on acceleration/deceleration of
the skull and brain that replicate the dynamics of damage due
to rotational forces leading to diffuse brain injury have been diffi-
cult to develop, due to the lower mass of the animal brain
(O’Connor et al., 2011; Johnson et al., 2012). The vast majority
of people with sports-related brain trauma have mild TBI with
concussion, without skull fracture or neuroimaging evidence of
contusions or bleedings due to direct crush injury to the brain
(Alexander, 1995; McCrory et al., 2009). Instead, these athletes
have subconcussive or concussive impact to the brain, due to
Figure 1. Molecular Pathophysiology of Concussion
A schematic flow chart of the molecular changes after rotational head injury that leads to concussion and knockout with loss of consciousness. Abbreviations:
NMDA, N-methyl-D-aspartate.
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this reason, it is questionable whether animal models based on
direct crush or compression injury are relevant models to study
the neurobiology of mild TBI.
Acute Cellular and Neurochemical Effects of TBI
Closed head injury with acceleration and deceleration forces to
the brain causes a multifaceted cascade of neurochemical
changes that affect brain function (see Figure 1). Although
detailed understanding of the pathophysiology of concussion
is lacking, studies using the mild fluid percussion model support
the idea that the initiating event is stretching and disrupting of
neuronal and axonal cell membranes, while cell bodies and
myelin sheaths are less affected (Spain et al., 2010). Resulting
membrane defects cause a deregulated flux of ions, including
an efflux of potassium and influx of calcium. These events
precipitate enhanced release of excitatory neurotransmitters,
particularly glutamate. Binding glutamate to N-methyl-D-aspar-
tate (NMDA) receptors results in further depolarization, influx of
calcium ions, and widespread suppression of neurons with
glucose hypometabolism (Giza andHovda, 2001; Barkhoudarian
et al., 2011). Increased activity in membrane pumps (to restore
ionic balance) raises glucose consumption, depletes energystores, causes calcium influx into mitochondria, and impairs
oxidative metabolism and consequently anaerobic glycolysis
with lactate production, which might cause acidosis and edema
(Giza and Hovda, 2001; Barkhoudarian et al., 2011).
Diffuse Axonal Injury
DAI, caused by shearing of fragile axons by acceleration/decel-
eration forces from the trauma, is the primary neuropathology of
TBI (Adams et al., 1989; Alexander, 1995; Meythaler et al., 2001;
Johnson et al., 2012). DAI is present also in patients with mild TBI
(Oppenheimer, 1968), and the severity of DAI is proportional to
the deceleration force (Elson and Ward, 1994). In patients with
TBI, DAI is notoriously difficult to identify using CT and conven-
tional MRI, although MRI is more sensitive (Kim and Gean,
2011). However, novel MRI techniques such as diffusion tensor
imaging (DTI) have been shown to be useful to asses axonal
integrity and to identify DAI in patients with mild TBI (Bazarian
et al., 2007; Mayer et al., 2010; Miles et al., 2008) and also in
athletes with mild sports-related concussive or subconcussive
TBI (Bazarian et al., 2012).
By histological techniques, DAI can be identified very early
(hours) after trauma and is characterized by sequential changes
with an acute shearing of axons, which leads to disrupted axonalNeuron 76, December 6, 2012 ª2012 Elsevier Inc. 889
Figure 2. The Tau Pathway and Tau Pathology in CTE
Schematic flow chart of the molecular changes related to tau phosphorylation and aggregation in repeated mild traumatic brain injury (TBI). Tau is a protein
located in the neuronal axons that, by binding to the microtubules through its microtubule-binding domains, promotes microtubule assembly and stability. Tau
has six isoforms that contain either three or four microtubule-binding domains and several phosphorylation sites, either threonine (T) or serine (S). Through
mechanisms which are unknown, TBI causes an imbalance in kinases and phosphates, which results in tau phosphorylation. Hyperphosphorylation of taumakes
it prone to aggregation into insoluble fibrils (paired helical filaments, PHF) and larger aggregates in the form of neurofibrillary tangles and neuropil threads.
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connection and in the end Wallerian degeneration (Johnson
et al., 2012). DAI with axolemmal disruption causes calcium
influx, neurofilament compaction, and microtubule disassembly.
Neurofilament compaction is an early event caused by calpain-
mediated proteolysis of neurofilament side arms or phos-
phorylation. Calcium influx triggers microtubule disassembly
(Giza and Hovda, 2001; Barkhoudarian et al., 2011). Cytoskeletal
pathology may have several mediators. In animal traumamodels
of axonal pathology, calcium homeostasis disruption results in
calpain-mediated proteolytic degradation of essential cytoskel-
etal proteins, such as neurofilament proteins. Calcium homeo-
stasis is the primary regulator of calpain activation; disruption
leads to increased intracellular-free calcium (McCracken et al.,
1999; McGinn et al., 2009; Saatman et al., 2010).
Microtubule disorganization may be a direct effect of dynamic
axon stretching. Ultrastructural analysis of axons displays imme-
diate breakage and buckling of microtubules postinjury, which
triggers progressive microtubule disassembly (Tang-Schomer
et al., 2010). This results in accumulation of organelles that
are transported in the axon, and axonal swelling called axonal
retraction balls, with eventual disconnection and axotomy
(Giza and Hovda, 2001; Barkhoudarian et al., 2011). Neuronal
damage with axonal bulbs and swellings is most commonly
located in the cortical sulci at the interface between gray and
white matter (Chen et al., 2004). MRI studies that use DTI show
that the extent of DAI after mild TBI is related to postconcussion890 Neuron 76, December 6, 2012 ª2012 Elsevier Inc.cognitive problems (Lipton et al., 2008; Niogi et al., 2008; Wilde
et al., 2008).
Tau Pathology and Tangle Formation
As early as the 1970s, Corsellis et al. (1973) reported neurofibril-
lary tangles in neocortical areas in boxers with CTE. Several
studies have since confirmed these findings of extensive tangle
pathology in postmortem studies (Dale et al., 1991; Tokuda et al.,
1991; Schmidt et al., 2001; Hof et al., 1992; Geddes et al., 1996).
In addition to neurofibrillary tangles, neuropil treads and glial
tangles are also elements of CTE (McKee et al., 2009).
Cortical tangles also constitute a key component of Alz-
heimer’s disease. But because they are found in many chronic
neurological diseases (Wisniewski et al., 1979) with different
etiology, it is possible that they represent a more general
response to neurodegenerative pathology. Indeed, their abun-
dance in CTE, which is caused by repeated brain trauma
episodes, further supports that they may represent a response
to brain damage. Tangles are found intracellularly in the cyto-
plasm of neurons and consist of thread-like aggregates of hyper-
phosphorylated tau protein (Grundke-Iqbal et al., 1986). Tau is
a normal axonal protein that binds to microtubules via its micro-
tubule-binding domains, thus promoting microtubule assembly
and stability. There are six different isoforms of tau, each con-
taining several serine or threonine residues that can be phos-
phorylated. In AD, tau is frequently found in a hyperphosphory-
lated form (Figure 2). Such tau phosphorylation reduces
microtubule binding, which causes disassembly of microtubules
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neuronal and synaptic function, increased propensity of tau
aggregation, and subsequent formation of insoluble fibrils and
tangles (Mandelkow and Mandelkow, 2012). In aggregate, these
cellular and molecular changes further compromise neuronal
function.
Tangles in boxers with dementia pugilistica/CTE are structur-
ally and chemically similar to those found in AD, in which CTE
tangles also consist of hyperphosphorylated and ubiquitinated
tau (Dale et al., 1991; Tokuda et al., 1991). Hyperphosphorylated
tau from dementia pugilistica and AD brains is phosphorylated at
the same amino acids, including the AT8 epitope, contains all six
tau isoforms, and shows the same relation between 3- and
4-repeat tau (Schmidt et al., 2001) (Figure 2). However, it should
be noted that the tangles are found in different populations of
cortical pyramidal neurons; in dementia pugilistica/CTE, tangles
are found in the superficial neocortical layers, while tangles in AD
are found in deep and in superficial layers (Corsellis et al., 1973;
Hof et al., 1992; McKee et al., 2009). Furthermore, tau pathology
in CTE is patchy and irregularly distributed, possibly related to
themany different directions of shearing forces induced by phys-
ical trauma (McKee et al., 2009).
Experimental studies in animals suggest that intra-axonal tau
accumulation and tau phosphorylation may be consequences
of repeated brain trauma. Controlled brain trauma in animal
models has been shown to increase tau immunoreactivity and
tau phosphorylation in the perinuclear cytoplasm and in elon-
gated neuritis (Tran et al., 2011). These abnormalities correlate
with injury severity (Tran et al., 2011). Studies on brain trauma
induced by rotational acceleration in experimental animals
show an accumulation of both tau and neurofilament proteins
in damaged axons (Smith et al., 1999). Treatment with g-secre-
tase inhibitors mitigates amyloid pathology but does not affect
TBI-induced tangle formation, suggesting that TBI-induced tau
pathology is not a downstream event of Ab accumulation and
plaque formation (Tran et al., 2011). The neurochemical distur-
bances that trigger tau pathology in CTE are not known in detail,
but recent studies show that TBI induces an abnormal intra-
axonal activation and accumulation in kinases that can phos-
phorylate tau (Tran et al., 2012). The kinase c-Jun N-terminal
kinase (JNK) is markedly activated in damaged axons, and inhi-
bition of JNK activity was found to reduce the accumulation of
both total and phosphorylated tau in injured axons (Tran et al.,
2012).
APP and Ab Generation with Plaque Formation
After identification of Ab as the key component of plaques in
AD, Roberts et al. (1990) re-examined brains from the classic
Corsellis report (Corsellis et al., 1973) to determine whether Ab
pathology may also be a key histopathological characteristic in
dementia pugilistica. Here, the authors demonstrated that all
brains from boxers with substantial tangle formation also had
extensive Ab deposits consisting of diffuse plaques (Roberts
et al., 1990). The intensity of Ab plaque deposition was compa-
rable to that found in AD cases (Roberts et al., 1990). The pres-
ence of Ab plaques after acute severe brain trauma was verified
in many reports, including studies on fresh surgically excised
brain tissue samples (Roberts et al., 1994; Ikonomovic et al.,
2004).Aggregation of Ab and plaque formation constitutes central
elements of AD. Ab is generated from amyloid precursor protein
(APP) by the concerted action of b-secretase and g-secretase
(Blennow et al., 2006). b-Secretase was identified as b-site
APP-cleaving enzyme 1 (BACE1), while g-secretase consists of
a complex with four components that include presenilin, nicas-
trin, Pen-2, and Aph-1. Presenilin is present in the active site of
the g-secretase complex (Blennow et al., 2006). Expression of
APP is highest in neurons and, under normal conditions, APP
(Koo et al., 1990; Ferreira et al., 1993; Kamal et al., 2000), b-sec-
retase (BACE1) and g-secretase (presenilin) (Sheng et al., 2003)
are translocated by axonal transport to the synapses, where APP
can be cleaved by the secretases, thus generating Ab (Kamal
et al., 2001).
Extensive research contends that APP has neurotrophic func-
tions, including promotion of axonal sprouting, neurite out-
growth, and synaptogenesis, which are important for neuronal
survival after axonal damage (Small, 1998; Small et al., 1999;
Alvarez et al., 1992; Xie et al., 2003). APP is upregulated in
response to brain trauma and administration of soluble a-secre-
tase-cleaved APP improves functional outcome and reduces
neuronal cell loss and axonal injury after experimental TBI in
animals (Thornton et al., 2006).
Studies on human brain tissue samples have demonstrated
that APP accumulates in neurons and axons after brain trauma
with axonal damage (McKenzie et al., 1994; Sherriff et al.,
1994; Gentleman et al., 1995; Ahlgren et al., 1996; Gleckman
et al., 1999). Postmortem studies on human brain tissue samples
from patients who sustained mild TBI but died of other causes
have shown that this APP accumulation occurs very rapidly
(within a few hours) after brain trauma and is present in cases
with mild trauma (Blumbergs et al., 1994; McKenzie et al.,
1996; Johnson et al., 2012). Besides APP, acute intra-axonal
Ab accumulation is a prevalent trait in human TBI (Smith et al.,
2003; Uryu et al., 2007; Chen et al., 2009). Release of b-amyloid
(especially Ab42) into tissue and plaque formation around
damaged axons occurs after APP accumulation and b-amyloid
production in damaged axons (Roberts et al., 1991; Graham
et al., 1995; Horsburgh et al., 2000a; Smith et al., 2003).
Studies on brain trauma induced by rotational acceleration in
animal experiments show an accumulation of APP and Abwithin
damaged axons throughout the white matter, which in a subset
of animals is accompanied by Ab diffuse plaques (Smith et al.,
1999; Li et al., 2010; Tran et al., 2011). After TBI, APP accumula-
tion, BACE1 and presenilin enzymes, and the Ab product all
accumulate in the terminal bulbs of disconnected axons and in
a limited number of neurons in cortical areas (Chen et al., 2004).
Experiments in AD transgenic mouse models suggest that the
degree of intra-axonal APP and Ab accumulation correlates with
injury severity (Tran et al., 2011) and that repetitive mild TBI
increases Ab deposition (Uryu et al., 2002). Appearance of Ab
accumulations was consistent with the morphology of injured
axons. Essentially all axonal Ab deposits were also positive for
APP and for neurofilament light protein, which is a well-estab-
lished marker for axonal damage (Tran et al., 2011). Intra-axonal
APP accumulation is an established marker for DAI and is the
gold standard to identify DAI in routine forensic medicine, for
example, in deaths frommotor vehicle accidents and suspectedNeuron 76, December 6, 2012 ª2012 Elsevier Inc. 891
Figure 3. Neurochemical Pathophysiology of APP and Ab in CTE
Schematic flow chart of themolecular changes in APP and Abmetabolism after repeatedmild traumatic brain injury (TBI). Traumatic brain injury initiates a process
resulting in parenchymal deposits of Ab, mainly in the form of diffuse plaques. A large body of data support that the increase in APP is part of a regenerative
response to trauma, while it is debated whether the increase in Abwith aggregation and plaque formationmay initiate a chronic degenerative process, or whether
it is simply an epiphenomena to neuronal damage. Abbreviations: APP, amyloid precursor protein; BACE1, b-site APP cleaving enzyme 1; CTE, chronic traumatic
encephalopathy.
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2002). The increase in APP expression after DAI is probably
related to the proposed role of APP for promoting axonal
outgrowth after injury (Chen and Tang, 2006).
Data from studies of brain trauma in humans and on experi-
mental rotational brain trauma in animals indicate that DAI is
a long-term process in which axons continue to degenerate
and swell during an extended period. In the disconnected axons,
both the substrate (APP) and the key enzymes (BACE1 and pre-
senilin) for Ab generation accumulate in the swollen axonal
bulbs, which may lead to abnormal APP metabolism (Chen
et al., 2004). Furthermore, this large intra-axonal APP reservoir
and canonical enzymes for Ab generation may result in abnormal
Ab overproduction and accumulation. Peptide aggregation in
axonal bulbs follows Ab overproduction. After Ab expulsion
from injured axons, accumulation occurs in the extracellular
space as diffuse plaques (Chen et al., 2004; see Figure 3).
Other Types of Possible Pathogenic Changes
Microglial Activation. Microglial cells play an important role in the
immune system in the brain and are key mediators of the inflam-
matory response after TBI. Experiments in animal TBI models
show that microglia rapidly migrate toward lesioned tissue,
and activated microglia form extended cytoplasmic processes892 Neuron 76, December 6, 2012 ª2012 Elsevier Inc.in direct contact with injured axons to form a potential barrier
between the healthy and injured tissue, suggesting that micro-
glial activation is a response to the axonal damage (Davalos
et al., 2005; Shitaka et al., 2011). This microglial response is
associated with an upregulation of both pro- and anti-inflamma-
tory genes, chemokines and other inflammatory mediators (Zie-
bell and Morganti-Kossmann, 2010). However, it is not settled
whether modulation of this inflammatory response to brain
traumamay have any therapeutic effects; on the one hand, phar-
macological reduction of microglial activation might reduce
inflammation and improve neuronal survival, but on the other
hand, microglial activation might stimulate axonal regeneration
after injury (Loane and Byrnes, 2010).
Regenerative Phenomena. Similar to other types of injury, TBI
seems to elicit a plasticity regenerative response that includes
dendritic and synaptic sprouting with increased dendritic arbor-
ization and synaptogenesis (for review, see Keyvani and Schal-
lert, 2002). While it is beyond the scope of this Review to go
into detail on the complex pattern of protein changes controlling
this regenerative response, it is worth briefly mentioning that
alterations in transcription factors c-Jun and ATF-3 have been
reported in TBI, suggesting that such factors may be important
in axonal regeneration after DAI (Greer et al., 2011). Furthermore,
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teins, including growth-associated protein GAP-43, have also
been implicated in neurite sprouting of disconnected damaged
axons after the acute phase of TBI (Christman et al., 1997).
TDP-43 Pathology. Other proteins that may be involved in CTE
pathogenesis include the transactivation responsive region de-
oxyribonucleic acid-binding protein 43 (called TAR DNA-binding
protein 43 or TDP-43). Intraneuronal TDP-43 accumulation was
initially considered a disease-specific aspect of frontotemporal
lobar degeneration with ubiquitin-positive inclusions (FTLD-U)
and amyotrophic lateral sclerosis (ALS) (Neumann et al., 2006).
Later studies have found that accumulation of TDP-43 is a feature
of other neurodegenerative diseases as well, such as AD and
dementia with Lewy bodies (Kadokura et al., 2009; King et al.,
2010) and several other diseases.
Recent studies have also shown that the widespread accumu-
lation of TDP-43 occurs in boxers and American football players
with CTE after repeated brain trauma in several gray matter
structures, e.g., brainstem, basal ganglia cortical areas, and
subcortical white matter (King et al., 2010; McKee et al., 2010).
TDP-43 accumulations in chronic neurodegenerative diseases
contain phosphorylated TDP-43 (Neumann et al., 2009). A study
using phosphorylation-dependent antibodies showed intra-
neuronal accumulation of nonphosphorylated, but not phos-
phorylated, TDP-43 after single TBI (Johnson et al., 2011).
Animal experiments suggest that axonal damage results in an
upregulation of TDP-43 expression together with a redistribution
of TDP-43 from the nuclear compartment to the cytoplasm
(Moisse et al., 2009; Sato et al., 2009). Taken together, these
data suggest that TDP-43 accumulation in CTE and after TBI
may be part of a physiological injury response (Johnson et al.,
2011).
Lack of a-Synuclein Pathology. Parkinsonism may be associ-
ated with CTE in boxers, for which the term pugilistic parkin-
sonism has been used. Some studies reported loss of neurons
in the substantia nigra in boxers with CTE (Corsellis et al.,
1973), similar to that found in Parkinson’s disease. However,
neuronal loss in athletes with CTE is observed in the absence
of Lewy bodies and the accumulation of a-synuclein, which is
themain component of Lewy body pathology seen in PD (McKee
et al., 2009).
APOE and Genetic Susceptibility to CTE
Apolipoprotein E (ApoE) was originally identified as a main
component of lipoproteins in plasma and has important func-
tions in cholesterol and lipid transport. Peripheral ApoE is
synthesized in the liver, but expression is also high in the CNS,
where ApoE is the dominant apolipoprotein, primarily synthe-
sized by astrocytes, although neurons and microglia also may
contribute to its production (Huang et al., 2004). Both animal
experiments and clinical studies in man have shown that after
brain injury, large amounts of membrane lipids are released
from the damaged axons, and in response astrocytes increase
ApoE expression, with release of ApoE to the extracellular space
to scavenge cholesterol and other lipids for reuse during axonal
and synaptic regeneration (Poirier et al., 1991, 1993; Horsburgh
et al., 2000b). Taken together, numerous studies suggest a
central role for ApoE in lipid delivery for growth and regeneration
of axons after neuronal injury.The APOE gene has three alleles (APOE ε2, APOE ε3, and
APOE ε4). APOE ε3 is the most common in the population.
Solid scientific evidence shows that theAPOE ε4 allele is a strong
susceptibility gene for AD (Roses, 1996). Similarly, Jordan et al.
(1997) reported that high-exposure boxers with the APOE ε4
allele were at increased risk of CTE compared to high-exposure
boxers without the APOE ε4 allele. All severely impaired boxers
had at least one APOE ε4 allele. This finding suggests that risk
of CTE after brain injury may be genetically determined. In agree-
ment, a meta-analysis of 14 cohort studies showed that the
APOE ε4 allele is associated with poor long-term outcome after
TBI, although it does not affect initial severity of the brain injury
(Zhou et al., 2008).
The mechanism for the association between the APOE ε4
allele and poor outcome after TBI remains controversial. As re-
viewed above, ApoE is a key mediator of cholesterol and lipid
transport in the brain and plays a crucial role in repair of
damaged axons after trauma (Poirier, 1994). A series of studies
demonstrated thatAPOE knockout neurons show defective neu-
rite sprouting, which can be restored by ApoE3 but not ApoE4
lipoproteins (Teter et al., 1999) and that increased ApoE4 expres-
sion reduces neuronal sprouting (Teter et al., 2002). These find-
ings suggest that the negative effect of ApoE4 on neuronal
sprouting is a gain of negative activity. In the human brain, the
APOE ε4 dose correlated inversely with dendritic spine density
in the hippocampus in AD patients and cognitively normal older
persons (Ji et al., 2003). Experiments in the human APOE-tar-
geted replacement mouse model show decreased spine density
and a marked impairment in reactive neuronal sprouting and
synaptogenesis in human APOE ε4 mice compared to APOE
ε3 mice, despite similar increases in ApoE expression levels
(White et al., 2001; Blain et al., 2006; Dumanis et al., 2009). These
data suggest that APOE ε4may act via impaired neuronal regen-
eration after brain insults. Another line of evidence links the
APOE ε4 allele with Ab generation and plaque formation. Severe
TBI in humans induces cortical Ab deposition in about 30%–50%
of patients (Roberts et al., 1991). Further studies showed that
the APOE ε4 allele is clearly overrepresented in trauma patients
who display Ab deposition (Nicoll et al., 1995, 1996). In a study on
AD transgenic mice exposed to TBI, mice coexpressing ApoE4
showed greater Ab deposition than ApoE3 mice and the pres-
ence of thioflavine-S-positive Ab plaques (Hartman et al.,
2002). These data suggest that ApoE4may trigger Ab deposition
and plaque formation as part of an acute phase response to brain
injury.
Based on the association between poor neurological long-
term outcome in carriers of the APOE ε4 allele after severe TBI
(Zhou et al., 2008) and findings suggesting that boxers with the
APOE ε4 allele suffer from more severe CTE (Jordan et al.,
1997), medical professionals have raised the issue of providing
genetic counseling for athletes. However, overall, these findings
should be interpreted with some caution, as a large prospective
study found no overall association between APOE genotype and
6 month outcome after TBI, except that the APOE ε4 allele
reduced the likelihood of a favorable outcome in children and
young adults (Teasdale et al., 2005). Furthermore, in the meta-
analysis of study on the effect of the APOE ε4 allele long-term
outcome after severe TBI (Zhou et al., 2008), the relative riskNeuron 76, December 6, 2012 ª2012 Elsevier Inc. 893
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relatively minor. So apart from ethical issues linked to coun-
seling, further studies are needed before such an approach
could be considered valuable from a preventative or clinical
standpoint.
Monitoring TBI Using Biomarkers
Currently, no imaging or biochemical measurements exist for
objectively identifying or quantifying whether or not an individual
has axonal damage or other types of brain injury. CSF is in direct
contact with the extracellular space of the brain, and thus
biochemical changes in the brain are reflected in CSF. Increased
CSF levels of biomarkers for axonal damage (e.g., tau and neuro-
filament light [NFL] protein) and glial cell damage (e.g., glial fibril-
lary acidic protein [GFAP] and S-100b) are found after acute
brain damage due to stroke and encephalitis (Hesse et al.,
2000; Nyle´n et al., 2006; Petzold et al., 2008). The degree of
increase of these biomarkers in CSF correlates with severity of
acute brain damage (Hesse et al., 2000; Nyle´n et al., 2006; Pet-
zold et al., 2008).
In a longitudinal study on amateur boxers, a pronounced
increase was found in the CSF level of NFL protein after a bout
(Zetterberg et al., 2006). The degree of increase in CSF NFL
also correlatedwith number and severity of received head blows.
CSF NFL returned toward normal levels after a 3month rest (Zet-
terberg et al., 2006). Similar but less pronounced changes were
found for CSF T-tau. The finding of an increase in CSF NFL that
correlates with severity of the bout in amateur boxers has
recently been verified in a larger, independent study (Neselius
et al., 2012).
NFL and tau are important constituents of neuronal axons, and
the CSF level of these proteins may serve as biomarkers for
axonal damage and degeneration (Grady et al., 1993; Olsson
et al., 2011). Increases in CSF NFL and T-tau in boxers most
likely reflect damage to neuronal axons from hits to the head.
In agreement with this interpretation, a marked increase in CSF
T-tau, which also correlates with a 1 year outcome, is found after
severe TBI (Franz et al., 2003; O¨st et al., 2006), and high CSFNFL
levels are found in patients with nerve tissue damage after spinal
cord injury (Gue´z et al., 2003).
These findings bring promise that CSF biomarkers may be
used for diagnostic and prognostic counseling of athletes. Post-
injury levels may give information on the severity of axonal
damage after a knockout, and longitudinal follow-up samples
may be used to monitor whether an increase in axonal proteins
have subsided and when it may be suitable for athletes to
resume sparring and competitions. However, due to its invasive
nature, lumbar puncturemay be difficult to introduce on a routine
basis in athletes. Analysis of biomarkers for brain damage in
blood samples may thus be preferable. An increase in serum
levels of neuron-specific enolase (NSE), a biomarker for neuronal
damage, was found in amateur boxers, even after an extended
resting period (Zetterberg et al., 2009), which suggests that
repetitive head trauma in boxers results in sustained release of
brain-specific protein to the peripheral circulation (Zetterberg
et al., 2009). Similarly, an increase in NSE, and also the glial
cell biomarker S-100b, was found in serum in amateur boxers
who received direct punches to the head compared with boxers894 Neuron 76, December 6, 2012 ª2012 Elsevier Inc.who received body punches but blocked and parried head
punches (Graham et al., 2011).
Future Prospects
As reviewed in this paper, knowledge on the neurobiology and
pathogenesis of contact sports-related mild TBI/concussion
and CTE is limited, and there is no treatment available. Another
risk group for CTE is military veterans who have been exposed
to repeated blast injury by firing heavy weapons or other types
of explosions. A recent study showed that militaries exposed
for blast injury may develop CTE with tau-linked pathology
similar to that found in some contact sport athletes (Goldstein
et al., 2012). Thus, there is a need of large longitudinal clinical
multicenter studies in military personnel exposed to blasts and
athletes involved in contact sports at risk for single or repeated
mild TBI. Such studies are needed to determine the incidence
and prevalence of concussion and CTE and to improve our
understanding of the relationship between repetitive acute brain
damage and its long-term sequelae.
Furthermore, there are no generally accepted guidelines for
a clinical diagnosis of CTE and no established biomarkers to
assist the clinician. For this reason, longitudinal clinical studies
employing biomarkers (MRI measures, PET imaging, and CSF
biochemical markers) in a similar manner to what has been
done in the U.S. Alzheimer’s disease neuroimaging initiative
study (Weiner et al., 2012) would be of importance. Such studies
could serve as the basis to develop novel biomarker-based clin-
ical consensus criteria for CTE and would also increase knowl-
edge on pathogenic mechanisms and the temporal evolution
of different forms of pathology.
In a similar way, despite the increasing number of neuropath-
ological studies on CTE, there are no generally accepted criteria
for how to distinguish neuropathological changes found in
CTE from those due to aging and AD. In addition, it is not estab-
lished whether there are differences in neuropathology between
CTE in American football players, with predominance of tau
pathology (McKee et al., 2009; Omalu et al., 2011) and dementia
pugilistica in boxers, with marked b-amyloid deposition and dif-
fuse plaques in addition to tau pathology (Roberts et al., 1990;
Tokuda et al., 1991). Longitudinal clinical studies with neuro-
pathological follow-up would serve to resolve these questions.
Experimental studies in animal models based on acceleration/
deceleration forces to the brain, which resemble the human
situation in mild TBI, will also be important to further explore
the complex neurochemical and neurobiological changes after
acute TBI. Knowledge on TBI neurobiology would benefit if
data from such animal studies would be verified in clinical
studies employingmolecular biomarkers aswell as in neuropath-
ological studies. Further, as reviewed above, the neurobiology of
CTE resembles that in AD. In mild TBI, axonal damage with DAI
triggers a series of neurobiological events that results in abnor-
malities in the metabolism of both tau and APP/Ab together
with abnormal aggregates of these proteins. A large body of
evidence also suggests that synaptic and axonal degeneration
with cytoskeletal abnormalities and deficits in axonal transport
play an early and important role in AD pathogenesis (Kanaan
et al., 2012). Since the initiating event(s) in TBI and CTE are
apparent, knowledge from TBI/CTE neurobiology may serve to
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genesis of AD, it is still under debate whether abnormalities in
tau and APP/Abmetabolism serve a pathogenic role and trigger
chronic neurodegeneration, or whether they represent epiphe-
nomena as tissue responses to the neuronal degeneration. While
there are certainly important differences between TBI/CTE and
AD, given the significant overlap and similarities in pathology,
there is still much that can be gained from closely cross-
comparing the molecular and cellular mechanisms involved in
both of these neuropathological processes.
At present, there is no pharmacological therapy for CTE. How-
ever, in contrast to most neurodegenerative disorders, actions
can be taken to prevent CTE, particularly in various professions
in which traumatic injuries are more likely to occur. For example,
in contact sports such as American football, increased aware-
ness of CTE has resulted in action plans by the National Football
League tomake the sport safer (Ellenbogen et al., 2010). In 2005,
the Word Medical Association (WMA) recommended the general
ban of boxing because of the basic intent of the sport to inflict
bodily harm on the opponent (WMA, 2005). Apart from such
a drastic action, there may be alternative ways to make contact
sports such as boxing safer, all of which are based on reducing
the number of, or impact from, head punches during a bout. A
logical option would be to introduce rule changes with fewer
rounds in professional boxing, since it is a logical conclusion
that the lower incidence of severe acute brain injury and deaths
in amateur as compared with professional boxing, as well as the
much lower incidence of chronic brain problems in retired
boxers, is related to the lower number of rounds in a bout in
amateur boxing. Experimental studies suggest that protective
equipment may give a reduction of the impact from a punch
(Bartsch et al., 2012), but it is noteworthy that boxing headgear
is mandatory only in amateur boxing and gloves are also thicker
with more padding. Thus, a change in rules to make headgear
and gloves with thicker padding also mandatory in professional
boxing and martial arts may reduce risk for CTE and is also rec-
ommended by the Word Medical Association (WMA, 2005).
Lastly, strictly adhering to the recent consensus guidelines for
removal of an athlete with concussion from play, recommended
by the large international sports organizations (McCrory et al.,
2009), in boxing may have a definite impact on both acute
concussions and severe brain injury and the prevalence of CTE.
Observations from professional athletes have begun to pro-
vide insight into TBI and CTE. As noted above, the development
of animal models of head injury is revealing underlying mecha-
nisms, and these approaches may prove to be useful in devel-
oping strategies to prevent and treat brain injury. Yet, it is clear
that TBI and CTE are significant public health issues and signif-
icant efforts are needed to improve prevention, diagnosis, and
treatment of these conditions.REFERENCES
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